Cardinal Health enters binding letter of intent to extend distribution agreements with CVS Health
CAH•Cardinal Health signed a binding letter of intent to extend its pharmaceutical distribution agreement with CVS Health through June 30, 2032. It reaffirmed fiscal 2027 non-GAAP EPS growth guidance of 13%-15%, or $12.40-$12.60, and long-term growth guidance of 12%-14%.
1. Agreement extension
Cardinal Health entered into a binding letter of intent to extend its pharmaceutical distribution agreements with CVS Health through June 30, 2032.
2. Guidance reaffirmed
Cardinal Health reaffirmed fiscal 2027 non-GAAP EPS growth guidance of 13%-15%, equivalent to $12.40-$12.60, and long-term non-GAAP EPS growth guidance of 12%-14%. LSEG IBES data put the fiscal 2027 EPS view at $12.57.
